The protective effect of different dialysis types on residual renal function in patients with maintenance hemodialysis: A systematic review and meta-analysis
- PMID: 30212979
- PMCID: PMC6156018
- DOI: 10.1097/MD.0000000000012325
The protective effect of different dialysis types on residual renal function in patients with maintenance hemodialysis: A systematic review and meta-analysis
Abstract
Background: Residual renal function (RRF) is an important determinant of mortality and morbidity in patients undergoing hemodialysis. Different dialysis types may have different effects on RRF. We therefore conducted this meta-analysis to examine the RRF protective effect of different dialysis types for hemodialysis patients.
Methods: A systematic search was performed on PubMed, EMbase, Web of Science, Chinese Biomedical Literature Database, Wanfang database, and China National Knowledge Infrastructure for randomized controlled trials and cohort studies. Dialysis types included low-flux hemodialysis (LFHD), high-flux hemodialysis (HFHD), hemodiafiltration (HDF), and hemodialysis and hemoperfusion (HD+HP). The mean of endogenous creatinine clearance rate (CCR) and urea clearance rate (Curea), or urine volume was used to estimate RRF [95% confidence interval (95% CI), 6.05-16.80].
Results: There were 12 articles involving 1224 patients, including 11 random controlled trials and 1 cohort study. Meta-analysis showed that the RRF protective effect of HFHD [mean difference (MD) = 1.48, 95% CI (2.11 to 0.86), P < .01] and HD+HP [MD = 0.41, 95% CI (0.69 to 0.12), P = .005] was better than that of LFHD, and the RRF decline rate was the lowest in HFHD group [MD = 0.13, 95% CI (0.17 to 0.09), P < .01]. Descriptive analysis showed that HDF could better protect RRF when compared with LFHD. However, there was no consistency among other interventions when removing LFHD due to limited data.
Conclusion: For patients undergoing maintenance hemodialysis, the HFHD, HD+HP and HDF may better protect RRF, compared with LFHD.
Conflict of interest statement
All authors declare that they have no conflict of interest.
Figures




Similar articles
-
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.Cochrane Database Syst Rev. 2001;(3):CD003234. doi: 10.1002/14651858.CD003234. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003234. doi: 10.1002/14651858.CD003234.pub2. PMID: 11687058 Updated.
-
Mortality on Hemodiafiltration Compared to High-Flux Hemodialysis: A Brazilian Cohort Study.Am J Kidney Dis. 2025 Sep;86(3):335-342.e1. doi: 10.1053/j.ajkd.2025.04.013. Epub 2025 Jun 9. Am J Kidney Dis. 2025. PMID: 40499884
-
Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review.Am J Kidney Dis. 2005 Mar;45(3):437-47. doi: 10.1053/j.ajkd.2004.11.008. Am J Kidney Dis. 2005. PMID: 15754266
-
Effects of different hemodialysis modalities combined with low-calcium dialysate on mineral metabolism and vascular calcification in maintenance hemodialysis patients with chronic kidney disease.J Appl Biomed. 2024 Dec;22(4):228-233. doi: 10.32725/jab.2024.027. Epub 2024 Dec 16. J Appl Biomed. 2024. PMID: 40033811 Clinical Trial.
-
Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.PLoS One. 2016 Apr 7;11(4):e0153157. doi: 10.1371/journal.pone.0153157. eCollection 2016. PLoS One. 2016. PMID: 27055286 Free PMC article.
Cited by
-
A comparative analysis of high-flux and low-flux dialysis in cervical cancer patients with obstructive renal failure showing no significantly improved renal function after catheterisation.Pak J Med Sci. 2021 Jul-Aug;37(4):1014-1019. doi: 10.12669/pjms.37.4.3515. Pak J Med Sci. 2021. PMID: 34290775 Free PMC article.
-
Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.Front Cell Infect Microbiol. 2022 Sep 27;12:639624. doi: 10.3389/fcimb.2022.639624. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36237423 Free PMC article.
-
Zero-contrast percutaneous coronary interventions to preserve kidney function in patients with severe renal impairment and hemodialysis subjects.Postepy Kardiol Interwencyjnej. 2019;15(2):137-142. doi: 10.5114/aic.2019.86008. Epub 2019 Jun 26. Postepy Kardiol Interwencyjnej. 2019. PMID: 31497045 Free PMC article.
-
The risk factors of autogenous arteriovenous fistula dysfunction in maintenance hemodialysis patients and the curative effect of personalized nursing.Am J Transl Res. 2021 May 15;13(5):5107-5116. eCollection 2021. Am J Transl Res. 2021. PMID: 34150099 Free PMC article.
-
Blood purification therapy in chronic renal failure and its impact on renal index, serological index, and inflammatory factors.Ann Med Surg (Lond). 2024 May 15;86(7):3856-3864. doi: 10.1097/MS9.0000000000002182. eCollection 2024 Jul. Ann Med Surg (Lond). 2024. PMID: 38989222 Free PMC article.
References
-
- Rosselli D, Rueda JD, Diaz CE. Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi J Kidney Dis Transpl 2015;26:733–8. - PubMed
-
- de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782–9. - PubMed
-
- Tanaka M, Yamashita T, Koyama M, et al. Impact of use of angiotensin II receptor blocker on all-cause mortality in hemodialysis patients: prospective cohort study using a propensity-score analysis. Clin Exp Nephrol 2016;20:469–78. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous